SR-4835 |
SR-4835 : ATP competitive inhibitor of CDK12, CDK13
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| CDK12 |
|
|
| CDK13 |
|
ATP competitive
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
SR-4835 was highly selective toward CDK12 and CDK13 when tested in a panel of over 450 kinases at 10 ...
Potency Cellular
In Vitro
CDK12
Mode of Action: ATP competitive
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1016/j.ccell.2019.09.004
CDK13
Mode of Action: ATP competitive
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1016/j.ccell.2019.09.004
In Vivo Validations
Mouse
Dose: 20 mg/Kg
Route of delivery:
Oral
Plasma half life:
3.95 h
Systemic clearance:
29.52 mL/min/kg
Cmax:
1301 ng/mL
Tmax:
2.67 h
Area Under the Curve::
23.27 uM*h
DOI Reference: 10.1016/j.ccell.2019.09.004
Chemical Information
| Molecular Formula | C21H20Cl2N10O |
| SMILEs | Cn1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOCC4)nc32)cn1 |
| InChI | InChI=1S/C21H20Cl2N10O/c1-31-10-12(8-26-31)33-11-25-18-19(29-21(30-20(18)33)32-2-4-34-5-3-32)24-9-17-27-15-6-13(22)14(23)7-16(15)28-17/h6-8,10-11H,2-5,9H2,1H3,(H,27,28)(H,24,29,30) |
| Molecular weight | 498.12 Da |
| AlogP | 0.0 |
| HBond acceptors | 11 |
| HBond donors | 2 |
| Atoms | 54 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.